)
)
Recursion Pharmaceuticals Investor Relations Material
Latest events
Status Update
Recursion Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Recursion Pharmaceuticals Inc
Access all reports
Segment Data
Access more data
Revenue by
Source
Operating revenue
Grant revenue
Expenses by
Financials
Recursion Pharmaceuticals, Inc. focuses on the development of therapeutics for the treatment of human disease by decoding biology. Their goal is to utilize automation technologies to industrialize drug discovery and replace ineffective trial-and-error drug screening with a streamlined process for identifying new therapeutics.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
RXRX
Country
🇺🇸 United States